Genix Ph. - search results

Australia - English - Department of Health (Therapeutic Goods Administration)

hemgenix etranacogene dezaparvovec 1 unit solution for intravenous infusion vial

csl behring australia pty ltd - etranacogene dezaparvovec, quantity: 1 u - injection, intravenous infusion - excipient ingredients: monobasic potassium phosphate; water for injections; potassium chloride; dibasic sodium phosphate; sodium chloride; polysorbate 20; hydrochloric acid; sucrose - this medicine has provisional approval in australia.,hemgenix? is an adeno-associated virus vector-based gene therapy indicated for treatment of adults with haemophilia b (congenital factor ix deficiency), without a history of factor ix inhibitors, who:,- currently use factor ix prophylaxis therapy, or,- have current or historical life-threatening haemorrhage, or repeated, serious spontaneous bleeding episodes.,the decision to approve this indication has been made on the basis of short-term efficacy and safety data from the clinical trial program. continued approval of this indication depends on confirmation of longer-term benefit from ongoing clinical trials.

Australia - English - Department of Health (Therapeutic Goods Administration)

genix 7.5mg meloxicam 7.5mg tablet blister pack

genesis pharma pty ltd - meloxicam, quantity: 7.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; croscarmellose sodium; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; macrogol 400; carnauba wax - relief of the signs & symptoms of osteoarthritis.